Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
GALT
#3043
Galectin Therapeutics Inc.
2.9
8
-1.32%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.32%
Variazione Mensile
-5.40%
Variazione di 6 mesi
-25.87%
Variazione Annuale
+104.11%
Chiusura Precedente
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
Volume
21
Mercati
Mercato Azionario Statunitense
Salute
GALT
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
57.16 M
59.36 M
59.44 M
61.9 M
63.18 M
—
Valuation ratios
Enterprise value
101.41 M
83.75 M
52.06 M
82.55 M
66.88 M
521.06 M
Price to earnings ratio
—
-3.98
-1.82
-2.35
-1.7
-13.87
Price to sales ratio
—
877.9
125.82
242.31
136.7
146.11
Price to cash flow ratio
—
-4.98
-2.26
-3.18
-1.92
-16.37
Price to book ratio
—
331.01
-2.04
-1.68
-0.76
-1.84
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.79
0.73
1.82
1.46
2.69
2.81
Return on equity %
1.04
34.18
1.14
0.66
0.45
0.33
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
21.87 K
6 885.46
8 812.96
7 216.5
31.11 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
22.12 K
6 961.58
9 506.02
8 001.19
38.53 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.46
4.63
1.58
1.77
0.49
2.1
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
0.02
0.02
0.03
0.19
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
0.42
0.52
0.55
0.67
0.49
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
0.68
0.31
0.43
0.24
0.76
Net current asset value per share
—
0.71
0.35
0.46
0.28
0.87
Tangible book value per share
—
0.01
0.56
1.02
1.67
7.28
Working capital per share
—
0.56
0.13
0.2
-0.29
-3.75
Book value per share
—
0.01
0.56
1.02
1.67
7.28
Notizie
Il direttore di Galectin Therapeutics Marc Rubin si dimette dal consiglio
Galectin Therapeutics director Marc Rubin resigns from board
Il CFO di Galectin Therapeutics vende azioni per 233.000 dollari
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Il titolo Galectin Therapeutics crolla dopo il feedback della FDA sul farmaco
Galectin Therapeutics stock plummets after FDA feedback on drug
La FDA fornisce feedback sul programma di sviluppo di belapectin di Galectin
FDA provides feedback on Galectin’s belapectin development program
Direttore di Galectin Therapeutics vende azioni per 1,05 milioni di dollari
Gli azionisti di Galectin Therapeutics eleggono membri del consiglio e approvano proposte chiave